OTUD5
OTU domain-containing protein 5
Also known as: DKFZp761A052, DUBA, OTUD5_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96G74
- Gene
- OTUD5
- Ensembl
- ENSG00000068308
- Chromosome
- X
- Canonical length
- 571 aa
- Protein class
- Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli fibrillar center,Cytosol
OverviewNCBI Gene
This gene encodes a member of the OTU (ovarian tumor) domain-containing cysteine protease superfamily. The OTU domain confers deubiquitinase activity and the encoded protein has been shown to suppress the type I interferon-dependent innate immune response by cleaving the polyubiquitin chain from an essential type I interferon adaptor protein. Cleavage results in disassociation of the adaptor protein from a downstream signaling complex and disruption of the type I interferon signaling cascade. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Oct 2008]
Canonical amino-acid sequenceUniProt
571 residues, UniProt reviewed canonical sequence.
>Q96G74|OTUD5
1 MTILPKKKPP PPDADPANEP PPPGPMPPAP RRGGGVGVGG GGTGVGGGDR DRDSGVVGAR
61 PRASPPPQGP LPGPPGALHR WALAVPPGAV AGPRPQQASP PPCGGPGGPG GGPGDALGAA
121 AAGVGAAGVV VGVGGAVGVG GCCSGPGHSK RRRQAPGVGA VGGGSPEREE VGAGYNSEDE
181 YEAAAARIEA MDPATVEQQE HWFEKALRDK KGFIIKQMKE DGACLFRAVA DQVYGDQDMH
241 EVVRKHCMDY LMKNADYFSN YVTEDFTTYI NRKRKNNCHG NHIEMQAMAE MYNRPVEVYQ
301 YSTGTSAVEP INTFHGIHQN EDEPIRVSYH RNIHYNSVVN PNKATIGVGL GLPSFKPGFA
361 EQSLMKNAIK TSEESWIEQQ MLEDKKRATD WEATNEAIEE QVARESYLQW LRDQEKQARQ
421 VRGPSQPRKA SATCSSATAA ASSGLEEWTS RSPRQRSSAS SPEHPELHAE LGMKPPSPGT
481 VLALAKPPSP CAPGTSSQFS AGADRATSPL VSLYPALECR ALIQQMSPSA FGLNDWDDDE
541 ILASVLAVSQ QEYLDSMKKN KVHRDPPPDK SLocalizationUniProt · AlphaFold · HPA
Whether an antibody against OTUD5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.55
- Highest tissue expression
- 57 nTPM
Expression across tissuesHPA
Tissue
- spleen: 57 nTPM
- cerebral cortex: 54 nTPM
- bone marrow: 54 nTPM
- cerebellum: 53 nTPM
- basal ganglia: 53 nTPM
- amygdala: 48 nTPM
Single-cell type
- neutrophils: 215 nCPM
- platelets: 151 nCPM
- plasma cells: 88 nCPM
- esophageal apical cells: 81 nCPM
- innate lymphoid cells: 80 nCPM
- pdcs: 77 nCPM
Immune cell
- NK-cell: 20 nTPM
- memory B-cell: 8.6 nTPM
- neutrophil: 8.3 nTPM
- eosinophil: 7.5 nTPM
- T-reg: 7.3 nTPM
- naive CD8 T-cell: 7.1 nTPM
Brain region
- pons: 84 nTPM
- hypothalamus: 83 nTPM
- cerebral cortex: 79 nTPM
- basal ganglia: 78 nTPM
- medulla oblongata: 78 nTPM
- midbrain: 77 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about OTUD5.
Disease | AllUniProt
Conditions OTUD5 is implicated in, by any mechanism.
- Multiple congenital anomalies-neurodevelopmental syndrome, X-linked (MCAND) MIM:301056
Disease | GeneticClinVar
9 pathogenic / likely-pathogenic of 151 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Multiple congenital anomalies-neurodevelopmental syndrome, X-linked
- Inborn genetic diseases
- OTUD5-related disorder
- Intellectual disability
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.17
- gnomAD pLI
- 1
- gnomAD missense Z
- 3.99
- DepMap mean gene effect
- -0.25
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- negative regulation of canonical Wnt signaling pathway
- negative regulation of type I interferon production
- neural crest cell differentiation
- positive regulation of TORC1 signaling
- positive regulation of TORC2 signaling
- protein deubiquitination
- protein K48-linked deubiquitination
- protein K63-linked deubiquitination
- proteolysis
- regulation of immune response
- response to lipopolysaccharide
Molecular functions
- cysteine-type deubiquitinase activity
- deubiquitinase activity
- K48-linked deubiquitinase activity
- K63-linked deubiquitinase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of OTUD5 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads OTUD5 as an antibody target. Whether an autoantibody or antibody against OTUD5 could matter depends on whether native OTUD5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
OTUD5 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label OTUD5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...